HydrochlorothiazideAntihypertensive AgentsLosartanSodium Chloride Symporter InhibitorsDiureticsHypertensionDrug CombinationsAmlodipineBlood PressureDrug Therapy, CombinationTetrazolesAngiotensin II Type 1 Receptor BlockersAtenololChlorthalidoneTriamtereneAngiotensin-Converting Enzyme InhibitorsHydralazineCalcium Channel BlockersAngiotensin Receptor AntagonistsEnalaprilThiazidesCaptoprilMethyldopaBiphenyl CompoundsBlood Pressure Monitoring, AmbulatoryIndapamideLisinoprilBenzimidazolesDouble-Blind MethodRats, Inbred SHRAdrenergic beta-AntagonistsDrug SynergismBenzothiadiazinesImidazolesTreatment OutcomeBlood Pressure DeterminationDrug InteractionsDoxazosinValineReninBendroflumethiazideTrichlormethiazideFurosemideDose-Response Relationship, DrugRenin-Angiotensin SystemHypertension, RenalAngiotensin IIBenzoatesUric AcidTime FactorsDihydropyridinesSpironolactoneFosinoprilHypertrophy, Left VentricularKidneyGuanabenzNifedipineClinical Trials as TopicCilazaprilIndenesSystoleNitrendipineHeart RateReceptor, Angiotensin, Type 1ReserpineTabletsRats, Inbred WKYClonidineHypertension, RenovascularBisoprololSodium Chloride SymportersRisk FactorsMetoprololFumaratesProspective StudiesPatient ComplianceFollow-Up StudiesPropranololAlbuminuriaRandom AllocationDihydralazineCardiovascular DiseasesDrug PrescriptionsCross-Over StudiesAldosteroneDiastoleAcebutololReceptor, Angiotensin, Type 2MinoxidilRandomized Controlled Trials as TopicPotassiumDrug UtilizationCreatinineReceptors, AngiotensinNordefrinPerindoprilRats, Sprague-DawleyEthacrynic AcidHypokalemiaAdrenergic alpha-Antagonists